Science-based, science serving
MILabs was founded in 2006 as a spin-off from the University Medical Centre Utrecht, the Netherlands. Today, a whole new line of molecular imaging systems with unsurpassed resolution has been developed which has received many international awards from the scientific community, supports many happy users worldwide and serves as the imaging platform for important discoveries in the fields of e.g. pharmacology, oncology, cardiology and neuroscience.
MILabs’ first commercial successes with U-SPECT and U-SPECT/CT were followed by rapid expansion of the company’s customer base throughout the world. There has been a continuum of new developments that further improved the performance and functionality of the imaging systems. In 2011, MILabs introduced VECTor, an extremely user-friendly, fully integrated simultaneous SPECT and PET imaging technology with uniform and isotropic 0.75 mm resolution PET. In addition, clinical SPECT systems with unmatched performance are currently being developed at MILabs. MILabs imaging systems provide simple, intuitive system operation and highly efficient workflow.
MILabs systems are built in different base configurations to best meet the researcher’s application needs, offering exceptional value, user-friendly operation, cost-effectiveness and extremely high reliability. The latest products include the new VECTor4 and U-SPECT4 series. Please watch the video below to see the introduction of MILabs new SPECT-PET-CT 4-series for preclinical imaging at the EANM 2014 presented by MILabs founder and CEO Freek Beekman: